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Abstract 
 
Fluconazole  is  a  bistriazole  commonly  prescribed  for  the 
treatment of various fungal infections caused by yeasts and 
dermatophytes. However, there have been several reports 
of  rare  Adverse  Drug  Reactions  (ADRs)  like  Fixed  Dose 
Eruption  (FDE),  Toxic  Epidermal  Necrolysis  and  Stevens 
Johnson  Syndrome  following  oral  administration  of 
fluconazole. We report a rare case of fluconazole induced 
oral mucosal lesions, mimicking herpes labialis, in a 34 year 
old  male  patient  receiving  oral  fluconazole  for  the 
treatment of allergic fungal sinusitis. 
 
Case report 
A  34  year  old  man  presented  with  multiple,  painless, 
shallow erosions, measuring about 1 cm in diameter, over 
the mucosal surface of the upper lip and the outer surface 
of the lower lip along with burning, itching and crusting. The 
erosions  developed  from  painful  vesicles  characteristic  of 
localised  herpes  simplex.  Tzanck  test  for  herpes  simplex 
infection was negative. The patient suffered from perennial 
allergic rhinosinusitis for one year which was treated with 
topical  steroids,  antibiotics  and  antihistaminics  leading  to 
intermittent  remission  of  symptoms.  A  CT  scan  of  the 
paranasal  sinuses  showed  opacification  of  both  the 
maxillary  and  anterior  ethmoid  sinuses  with  diffuse 
intrasinus area of increased attenuation, suggesting fungal 
sinusitis.  Hence,  oral  fluconazole  150mg  once  daily  was 
started  presumptively  for  a  week.  History  revealed  that 
fluconazole  treatment  was  concomitantly  associated  with 
the  development  of  herpes  labialis-like  vesicles.  The  first 
episode of blistering  started after the intake of the third 
tablet  of  fluconazole.  There  were  no  other  constitutive 
symptoms.  Therefore,  a  Fixed  Dose  Eruption  (FDE)  to 
fluconazole  was  suspected.  Oral  provocation  test  with 
fluconazole  150mg  was  performed  in  the  following  week 
with the patient’s consent. The patient developed burning 
sensation and erythema on the mucosal aspect of both the 
lips, developing into herpes-like vesicles at the same site on 
the very next day and painful erosions  
 
 
 
 
 
 
 
by  the  fourth  day,  mimicking  the  earlier  episode.  (Figure 
1)The erosions healed within a week of stopping fluconazole 
and the patient continued receiving treatment for allergic 
rhinosinusitis.  The  ADR  was  reported  to  the  peripheral 
pharmacovigilance centre of the state under the National 
Pharmacovigilance Programme India. 
 
 
Figure  1.  Pre  and  post  provocative  (left  and  right  respectively) 
fluconazole induced lip lesions. 
 
Discussion 
Brocq  in  1894  was  the  first  to  introduce  the  term  FDE, 
although the phenomenon was described by Bourns 5 years 
earlier.
1  FDEs  usually  occur  as  a  solitary  pruritic, 
erythematous  macule  which  evolves  into  an  oedematous 
plaque. Vesicles and bullae with a prominent hemorrhagic 
component may be present in the later stages.
2 Bullous FDEs 
mimicking  herpes  simplex  virus  infection  too  has  been 
described in the past.
3 
 
FDE is characterized by single or multiple skin lesions that 
occur at the  same  site each time a drug  is administered. 
However, the number and size of sites may increase after 
each exposure. Lesions are usually round or oval and well 
defined.  Swelling  and  redness  of  skin  are  typically  seen 
within 30 minutes to eight hours after exposure. The exact 
mechanism underlying FDEs is not known but immunological 
studies strongly indicate a role of the immune system. The 
drug  may  act  as  a  hapten  and  bind  to  the  protein 
component  in  melanocytes  or  dyskeratotic  keratinocytes 
forming  a  drug-protein  complex  which  is  then  detected, 
processed and presented to lymphocytes in the dermis or 
regional lymph nodes by Langhans’ cells as seen in allergic 
contact dermatitis. There is subsequent activation of B and T 
lymphocytes producing lymphokines and antibodies which 
cause inflammation and damage to cells in the basal layer. 
 
The  most  common  drug  causing  FDEs  is  cotrimoxazole 
(sulfamthoxazole/trimethoprim),  others  include 
tetracycline,  metamizole,  phenylbutazone,  paracetamol, 
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acetyl  salicylic  acid,  mefenamic  acid,  metronidazole, 
tinidazole,  chlormezanone,  amoxicillin,  ampicillin, 
erythromycin,  griseofulvin,  phenobarbitone,  diclofenac, 
indomethacin,  ibuprofen,  diflunisal,  pyrantel  pamoate, 
clindamycin, allopurinol,  and albendazole.
4  
 
The first case of fluconazole induced FDE was reported in 
year  1994  by    Morgan  and  Carmichael,  where  they 
described  the  reaction  in  a  27  year  old  man  with  an  18 
month  history  of  15  episodes  of  recurrent  rash  on  the 
extensor surfaces of his elbows.
5 In the second case, a local 
provocation  with  10%  fluconazole  test  in  petrolatum 
applied at the site of a previous lesion of FDE reproduced 
the eruption clinically and histopathologically in a 36 year 
old  woman.
6  Subsequently  few  more  case  reports 
implicated  the  causation  of  FDEs  with  fluconazole  from 
limited  skin  involvement  to  extensive  generalized 
lesions.
7,8,9,10  The  most  affected  sites  for  eruptions  were 
limbs, palmar and plantar areas as well as the oral cavity 
and lips.
11 A report of palatal FDE due to fluconazole has 
also been published in the past.
12 
 
Most previous studies on FDE due to drugs demonstrated a 
higher occurrence in men compared to women
4 that is in 
congruence with our finding as well. However, majority of 
the  FDEs  due  to  fluconazole  occurred  in  women  as 
compared to men.
11 Only one case of fluconazole induced 
recurrent  vesicles  on  the  lower  lip,  mimicking  herpes 
simplex virus infection, in a 23 year old woman, has been 
reported so far.
 13 In this case the lesions developed after 6 
months  of  recurrent  fluconazole  intake  for  Chronic 
Recurrent Vulvovaginal Candidiasis (CRVC). Oral provocation 
test  with  increasing  doses  of  fluconazole  in  the  above 
patient produced herpes like vesicles within one day, at the 
same site. Other antifungals implicated in causing FDEs are 
terbinafine
14,  griseofulvin
15,  ketokonazole
16,  itraconazole
17 
and nystatin.
18 
 
Fluconazole is generally well tolerated but the possibility of 
it causing sensitization and allergic reactions should be born 
in mind, especially in case of long term therapy in patients 
with  recurrent  infections.  Any  new,  localised  skin  lesion, 
during  the  course  of  such  therapy,  should  be  considered 
potentially drug induced unless proved otherwise. 
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